The patients with anaplastic thyroid cancer were treated with CAR-NK immune cells combined with PD-1 monoclonal antibody, and the safety and tolerability of the patients were observed and evaluated.
Age 18-75 years (including boundary values), male or female.
Be diagnosed with anaplastic thyroid cancer histopathologically with a measurable lesion≥1cm.
Liver and kidney function is good, and can tolerate treatment.
Be able to cooperate with the completion of treatment and follow-up work.
Need to breastfeed the baby or have fertility needs；
Immune system diseases;
Diseases of the blood system;
Mental system diseases;